Homology Medicines, Inc. (FIXX): $6.81

-0.22 (-3.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Homology Medicines Inc (FIXX) Price Targets From Analysts

Use the tables below to see what analysts covering Homology Medicines Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
10 $37 $14 $27 $7.03 284.07%

The Trend in the Analyst Price Target


Over the past 133 days, FIXX's average price target has gone down $2.

Over the past 318 days, FIXX's average upside potential has been 155.14%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-05-27 8 37 24 32.50 14.80 119.59%
2020-06-25 9 37 24 32.22 16.30 97.67%
2020-07-22 9 37 24 32.22 16.04 100.87%
2020-08-13 9 37 24 30.22 11.19 170.06%
2020-10-27 9 37 18 29.56 11.18 164.4%
2020-11-10 9 37 15 29.00 9.61 201.77%
2020-11-19 8 37 15 28.88 9.72 197.12%
2020-11-28 9 37 15 29.00 9.77 196.83%
2020-12-07 9 37 15 29.00 9.61 201.77%
2020-12-10 9 37 15 29.00 9.88 193.52%
2020-12-19 9 37 15 29.00 12.34 135.01%
2020-12-26 9 37 15 29.00 12.65 129.25%
2021-01-02 9 37 15 29.00 11.29 156.86%
2021-01-09 9 37 15 29.00 12.77 127.09%
2021-01-16 9 37 15 28.44 12.94 119.78%
2021-01-23 9 37 15 28.44 13.29 114%
2021-01-30 9 37 15 28.44 12.15 134.07%
2021-02-06 9 37 15 28.44 13.78 106.39%
2021-02-13 9 37 15 28.44 13.83 105.64%
2021-02-20 9 37 15 28.44 12.05 136.02%
2021-02-27 9 37 15 28.44 10.74 164.8%
2021-03-06 10 37 14 27.00 9.46 185.41%
2021-03-13 10 37 14 27.00 9.86 173.83%
2021-03-20 10 37 14 27.00 10.70 152.34%
2021-04-03 10 37 14 27.00 9.62 180.67%
2021-04-10 10 37 14 27.00 7.32 268.85%

FIXX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.32 5 5 1 0 0 11

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • FIXX has a greater upside potential (average analyst target price relative to current price) than 95.38% of all US stocks.
  • FIXX has a less variance in analysts' estimates than 7.83% of all US stocks.
  • FIXX has a higher number of analysts covering the stock than 97.79% of stocks in the small market cap category.
  • Homology Medicines Inc's average analyst price target is higher than 65.4% of stocks in the small market cap category.

In the Pharmaceutical Products industry, KPTI, AXLA and CBAY are the three stocks most similar to Homology Medicines Inc regarding the price target and analyst recommendation information presented here.

Is FIXX a Buy, Hold or Sell? See the POWR Ratings now!



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8064 seconds.